Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Children With Sickle Cell Anaemia in Eastern and Southern Africa: a Double Blind Randomised Trial (CHEMCHA)
Latest Information Update: 18 Sep 2023
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; Pyrimethamine/sulfadoxine
- Indications Malaria
- Focus Therapeutic Use
- Acronyms CHEMCHA
- 12 Sep 2023 Status changed from active, no longer recruiting to completed.
- 05 Apr 2023 Trial design published in the Trials
- 05 Sep 2022 Status changed from recruiting to active, no longer recruiting.